By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Hologic announced after the close of the market on Thursday that it has received regulatory approval in the US of its automated system for use with the company's human papillomavirus test.

The approval from the US Food and Drug Administration is for the Cervista HTA high-throughput automation system to be used with Hologic's Cervista HPV HR test, which was approved by the agency in 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.